Back

Improving outcomes in HFpEF with GLP-1 receptor agonist

29 August 2026 (10:20 - 10:30)
Organised by: Logo
Congress Presentation Part of: Disease of the thick heart: case-based discussion Cardiac Hypertrophy Open Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Leslie Cho

Cleveland Clinic, Cleveland (United States of America)

4 More presentations in this session

Presentation thumbnail
Brave new world of precision diagnosis and therapies
Doctor M. Desai (Cleveland, US)
Slides Video
Presentation thumbnail
Phenotypic convergence or causal cascade: stenosis, disarray, and infiltration
Professor W. Jaber (Cleveland, US)
Slides Video
Presentation thumbnail
The enzyme enigma
Doctor S. Keen (Cleveland, US)
Slides Video
Presentation thumbnail
Disease of the thick heart - panel discussion

Access the full session

Session thumbnail
Disease of the thick heart: case-based discussion
Video

The Event

Event poster

ESC Congress 2026

29 August 2026 10:20 CET
You may be interested in
thumbnail
Congress Session
GLP-1RAs in obesity-related HFpEF: a new era in treatment
31 August 2025
thumbnail
Congress Presentation
In the clinic: obesity-related HFpEF.
22 May 2022
thumbnail
Congress Presentation
GLP-1 receptor agonist (GLP-1 RA) and gastric inhibitory polypeptides (GIPs) in HFpEF
30 August 2025
thumbnail
Congress Session
What's the next STEP in HFpEF?
22 May 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources